Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Antibodies to alpha-synuclein and uses thereof Filling date: 6 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: INDAZOLE CARBOXAMIDES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40 Filling date: 6 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Macrocycles as factor XIA inhibitors Filling date: 6 Sep 2025 Issue date: 5 Oct 2021 |
Application | Utility: PROTEIN FRAGMENTATION CONTROL STRATEGY BY RE-OXIDATION IN DOWNSTREAM CHROMATOGRAPHY Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: METHODS FOR DETECTING ANTI-DRUG ANTIBODIES Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 30 Sep 2021 |
Grant | Utility: [1,2,4]Triazolo[4,3-A]pyridinyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Grant | Utility: Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Application | Utility: COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Phenylpyrrolidinone formyl peptide 2 receptor agonists Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Activatable anti-CTLA-4 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9 Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: OX-40 AGONIST, PD-1 PATHWAY INHIBITOR AND CTLA-4 INHIBITOR COMBINATION FOR USE IN A METHOD OF TREATING A CANCER OR A SOLID TUMOR Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: PROCESS FOR PREPARING INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Grant | Utility: Combination of DR5 agonist and anti-PD-1 antagonist and methods of use Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: PET-imaging immunomodulators Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: FGF-21 FORMULATIONS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: TREATMENT OF LAG-3 POSITIVE TUMORS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS OF PRODUCING RECOMBINANT PROTEINS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SINGLE PASS TANGENTIAL FLOW FILTRATION HYBRID CONFIGURATIONS FOR ENHANCING CONCENTRATION OF MACROMOLECULE SOLUTIONS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: CYCLOBUTANES- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: METHODS OF PURIFYING PROTEINS Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR PRODUCING A COMPOSITION Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Treatment of Hodgkin lymphoma using an anti-PD-1 antibody Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Application | Utility: LAG-3 Combination Therapy for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 5 Aug 2021 |
Grant | Utility: Compositions for cell bioproduction and methods of using the same Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Spirocyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: 5-membered and bicyclic heterocyclic amides as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: ROR .gamma. modulators Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Treatment of renal cell carcinoma Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Small molecule inhibitors of Galectin-3 Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Treatment of lung cancer using a combination of an anti-PD-1 antibody and an anti-CTLA-4 antibody Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 22 Jul 2021 |
Grant | Utility: Immunomodulators acting as antagonists of PD-1 Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Showing 200 to 250 of 772 patents.